William Newell

William Newell is a Senior Bioprocess Engineer at Molecular Devices, where responsibilities began in March 2023, following the company's acquisition of Cellesce Ltd, where William served as Manufacturing Manager from July 2019 to March 2023. Previously, William held the position of Senior Process Engineer at ReNeuron from March 2015 to July 2019, leading the development of a manual cell therapy process for a Phase IIb clinical study. Earlier experience includes roles at Oxford MESTAR Ltd as a Bioprocess Engineer and at Cavendish Nuclear as an Assistant Process Engineer, contributing to major nuclear decommissioning projects. Academic achievements include a Master of Engineering in Biochemical Engineering from the University of Bath, completed in 2014, alongside research experience at the University of Melbourne focused on advancements in Cochlear Implants.